The effect of statins on advanced prostate cancer patients with androgen deprivation therapy or abiraterone/enzalutamide: A systematic review and meta-analysis.
Hui YangLizhen PangXiaopeng HuWei WangBifang XuXiaodong ZhangLihong LiuPublished in: Journal of clinical pharmacy and therapeutics (2020)
The review indicated that the use of statins in combination with ADT was associated with better all-cause survival and cancer-specific survival in patients with advanced PCa. Randomized controlled trials should be conducted to establish efficacy of statins among PCa patients.
Keyphrases
- prostate cancer
- cardiovascular disease
- end stage renal disease
- randomized controlled trial
- radical prostatectomy
- ejection fraction
- newly diagnosed
- chronic kidney disease
- papillary thyroid
- peritoneal dialysis
- prognostic factors
- free survival
- squamous cell carcinoma
- patient reported outcomes
- young adults
- patient reported
- cell therapy
- smoking cessation